Loading...
Pierre Fabré
Do not exceed the recommended daily dose, keep out of reach of children.
Information relating to the precautions for use (drug interactions, contraindications, special warnings, adverse effects, etc.) as well as the dosage are detailed in the medicine's leaflet.
Report an adverse effect
Post Myocardial Infarction
Adjuvant treatment for secondary prevention of myocardial infarction, in combination with reference treatments (including statins, anti-platelet agents, beta-blockers and angiotensin-converting enzyme inhibitors).
C.I.P. reference : 3400935702586
28 unités
Indication / Contre-indication : Do not exceed the recommended daily dose, Keep out of reach of children
‹ Return Ask a question ›
Photo non contractuelle - All prices include VAT - excluding delivery costs. Page updated on 18/11/2024
3 october 2024
17 september 2024
> See all news
11 september 2023
1 september 2023
> See all tips